Neogen Chemicals Ltd. has announced a Board meeting scheduled for Saturday, March 7, 2026. The primary agenda is to evaluate and approve a proposal for raising capital through a Preferential Issue of equity shares. This action will be undertaken pursuant to Chapter V of the ICDR Regulations. Additionally, the company has implemented an immediate closure of the Trading Window for designated persons until 48 hours post-meeting conclusion.
Board Meeting Announced for Capital Raise
Neogen Chemicals Ltd. has formally informed the stock exchanges regarding a forthcoming meeting of its Board of Directors, scheduled to convene on Saturday, March 7, 2026. The announcement, made on March 4, 2026, outlines the core purpose of this assembly.
Proposal for Preferential Issue
The primary item on the agenda is to consider, evaluate, and approve a proposal for raising funds. This capital infusion is planned to be executed through the issuance of equity shares via a Preferential Issue. The price and consideration for this issue will be determined in accordance with Chapter V of the ICDR Regulations, subject to subsequent necessary approvals from the members and relevant statutory authorities.
Trading Window Closure
In adherence to the applicable insider trading regulations and the company’s internal Code of Conduct, the company has enforced an immediate closure of the Trading Window. This closure applies to all designated persons, their immediate relatives, connected persons, and legitimate insiders. The Trading Window will remain shut until 48 hours following the conclusion of the Board Meeting held to discuss the fundraising proposal.
Source: BSE
